Cita APA (7a ed.)
(2009). Legacy Products and Process Monitoring Raise Concern in Revised Process Validation Guidance. BioPharm International, 22(4), 14-15.
Cita Chicago Style (17a ed.)
"Legacy Products and Process Monitoring Raise Concern in Revised Process Validation Guidance." BioPharm International 22, no. 4 (2009): 14-15.
Cita MLA (9a ed.)
"Legacy Products and Process Monitoring Raise Concern in Revised Process Validation Guidance." BioPharm International, vol. 22, no. 4, 2009, pp. 14-15.
Precaución: Estas citas no son 100% exactas.